Is the NBA Pro-Marijuana Now?
Not Only Did the Head of the NBA’s Player Union Join the Board of Cresco Labs, the League Suspended Testing for Marijuana Use. The National Basketball Association will return July 31 under a “bubble” system in Orlando. Only 22 teams will compete in an abbreviated regular season before playoffs commence. The teams will be
Vernon Pub Opens Cannabis Store
Highlander Cannabis Becomes Newest Addition to Squires Four Public House on Stickle Road Nestled within Squires Four Public House on Stickle Road, Highlander Cannabis quietly opened its doors to the public June 1. Pub and liquor store owner for the past 12 years, Serry Massoud said the move into the world of legalized recreational
Hidden Potential of Flavonoids in Cannabis?
Many of the Compounds Found Within the Cannabis Plant are Gaining Increased Attention, but Some Still are not Widely Understood; an Example of This is a Group Known as Flavonoids. Flavonoids are a group of phytonutrients (plant chemicals) which, along with carotenoids, are responsible for the vivid colour, and often taste, found in plants
Cannabis Legalization may Help Fight Racial Injustice
The National Organization for the Reformation of Marijuana Laws (NORML), Recently Released a Statement Detailing How Cannabis Advocates can Play a Role in Enacting Racial Justice in America. Racial inequalities have long existed in enforcing drug policies. According to analysis by the American Civil Liberties Union (ACLU), African Americans are close to four times
Saanich Company to Produce Hemp Based Wipes
Rigorous Cleaning Protocols Prompted by the Pandemic Have Given a Saanich-Based Company, in the Disposable-Wipes Business, a Potentially Bright Future Bast Fibre Technologies Inc., a natural-fibre engineering company with headquarters at the Vancouver Island Technology Park, said it has secured $4.5 million in equity financing that will allow it to complete trials and enable
The White House is Reviewing a Plan for CBD Research
The Food and Drug Administration (FDA) Submitted Draft Guidance on the Issue Last Week to the White House Office of Management and Budget (OMB) Details about the document—titled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research”—are sparse. But an FDA spokesperson indicated to Marijuana Moment that it’s related to the agency’s ongoing work
